Genscript Biotech Corp. (GNNSF)
4.15
-0.45
(-9.78%)
USD |
OTCM |
Aug 26, 16:00
Genscript Biotech Max Drawdown (5Y) : 80.19% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 80.19% |
| June 30, 2026 | 80.19% |
| May 31, 2026 | 80.19% |
| April 30, 2026 | 80.19% |
| March 31, 2026 | 80.19% |
| February 28, 2026 | 80.19% |
| January 31, 2026 | 80.19% |
| December 31, 2025 | 80.19% |
| November 30, 2025 | 80.19% |
| October 31, 2025 | 80.19% |
| September 30, 2025 | 80.19% |
| August 31, 2025 | 80.19% |
| July 31, 2025 | 80.19% |
| June 30, 2025 | 80.19% |
| May 31, 2025 | 80.19% |
| April 30, 2025 | 80.19% |
| March 31, 2025 | 80.19% |
| February 28, 2025 | 80.19% |
| January 31, 2025 | 80.19% |
| December 31, 2024 | 80.19% |
| November 30, 2024 | 80.19% |
| October 31, 2024 | 80.19% |
| September 30, 2024 | 80.19% |
| August 31, 2024 | 80.19% |
| July 31, 2024 | 80.19% |
| Date | Value |
|---|---|
| June 30, 2024 | 80.19% |
| May 31, 2024 | 73.58% |
| April 30, 2024 | 71.70% |
| March 31, 2024 | 67.30% |
| February 29, 2024 | 67.30% |
| January 31, 2024 | 67.30% |
| December 31, 2023 | 69.00% |
| November 30, 2023 | 69.00% |
| October 31, 2023 | 69.00% |
| September 30, 2023 | 69.00% |
| August 31, 2023 | 69.00% |
| July 31, 2023 | 69.00% |
| June 30, 2023 | 69.00% |
| May 31, 2023 | 69.00% |
| April 30, 2023 | 69.00% |
| March 31, 2023 | 69.00% |
| February 28, 2023 | 69.00% |
| January 31, 2023 | 69.00% |
| December 31, 2022 | 69.00% |
| November 30, 2022 | 69.00% |
| October 31, 2022 | 69.00% |
| September 30, 2022 | 69.00% |
| August 31, 2022 | 69.00% |
| July 31, 2022 | 69.00% |
| June 30, 2022 | 69.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Charles River Laboratories International, Inc. | 78.23% |
| Trajan Group Holdings Ltd. | -- |
| Fortrea Holdings, Inc. | -- |
| ICON plc | 76.87% |
| IQVIA Holdings, Inc. | 51.52% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -26.51 |
| Beta (5Y) | 0.9178 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 67.05% |
| Historical Sharpe Ratio (5Y) | -0.2695 |
| Historical Sortino (5Y) | -0.5581 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 26.84% |